Pricing
Login
Home
Charts
Search
Watchlist
Products

Symbiotec Pharmalab Ltd

SYMBIOTEC
₹1,598.60-0.39%20 Nov 2026
Reports
Pharma API

Symbiotec Pharmalab Ltd

SYMBIOTEC
₹1,598.60
-0.39%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹10,272Cr
Close
Close Price
₹1,598.60
Industry
Industry
Pharma API
PE
Price To Earnings
75.80
PS
Price To Sales
11.82
Revenue
Revenue
₹869Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2025Sep 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
203196245218280
Growth YoY
Revenue Growth YoY%
7.443.2
Expenses
ExpensesCr
145145183173188
Operating Profit
Operating ProfitCr
5850624592
OPM
OPM%
28.525.725.320.732.7
Other Income
Other IncomeCr
30000
Interest Expense
Interest ExpenseCr
56766
Depreciation
DepreciationCr
1111202222
PBT
PBTCr
4533351864
Tax
TaxCr
15148312
PAT
PATCr
3019281452
Growth YoY
PAT Growth YoY%
-53.0169.1
NPM
NPM%
14.79.811.26.518.5
EPS
EPS₹
5.43.54.82.28.2
QuarterJun 2025Sep 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
203196245218280
Growth YoY
Revenue Growth YoY%
7.443.2
Expenses
ExpensesCr
145145183173188
Operating Profit
Operating ProfitCr
5850624592
OPM
OPM%
28.525.725.320.732.7
Other Income
Other IncomeCr
30000
Interest Expense
Interest ExpenseCr
56766
Depreciation
DepreciationCr
1111202222
PBT
PBTCr
4533351864
Tax
TaxCr
15148312
PAT
PATCr
3019281452
Growth YoY
PAT Growth YoY%
-53.0169.1
NPM
NPM%
14.79.811.26.518.5
EPS
EPS₹
5.43.54.82.28.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
633682567716752869
Growth
Revenue Growth%
7.7-16.926.44.915.7
Expenses
ExpensesCr
439552498545550631
Operating Profit
Operating ProfitCr
19413069171202238
OPM
OPM%
30.619.112.223.926.927.4
Other Income
Other IncomeCr
73674-6
Interest Expense
Interest ExpenseCr
62771625
Depreciation
DepreciationCr
222629394353
PBT
PBTCr
17310539132147153
Tax
TaxCr
482815315043
PAT
PATCr
124772510197110
Growth
PAT Growth%
-37.8-68.2312.9-4.413.4
NPM
NPM%
19.611.34.314.212.912.6
EPS
EPS₹
113.071.021.591.588.519.1
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
633682567716752869
Growth
Revenue Growth%
7.7-16.926.44.915.7
Expenses
ExpensesCr
439552498545550631
Operating Profit
Operating ProfitCr
19413069171202238
OPM
OPM%
30.619.112.223.926.927.4
Other Income
Other IncomeCr
73674-6
Interest Expense
Interest ExpenseCr
62771625
Depreciation
DepreciationCr
222629394353
PBT
PBTCr
17310539132147153
Tax
TaxCr
482815315043
PAT
PATCr
124772510197110
Growth
PAT Growth%
-37.8-68.2312.9-4.413.4
NPM
NPM%
19.611.34.314.212.912.6
EPS
EPS₹
113.071.021.591.588.519.1
Sales CAGR
1 Year16%
3 Years15%
5 Years7%
TTM-
EBITDA CAGR
1 Year18%
3 Years51%
5 Years4%
TTM-
PAT CAGR
1 Year13%
3 Years65%
5 Years-2%
TTM-
Avg. ROCE
1 Year12%
3 Years13%
5 Years12%
TTM12%
CFO / EBITDA
1 Year73%
3 Years67%
5 Years61%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111111111113
Reserves
ReservesCr
5105886117048041,137
Current Liabilities
Current LiabilitiesCr
225189228351473528
Non Current Liabilities
Non Current LiabilitiesCr
2328140229292104
Total Liabilities
Total LiabilitiesCr
7688159901,2951,5801,781
Current Assets
Current AssetsCr
423425400508493486
Non Current Assets
Non Current AssetsCr
3453905907871,0871,295
Total Assets
Total AssetsCr
7688159901,2951,5801,781
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111111111113
Reserves
ReservesCr
5105886117048041,137
Current Liabilities
Current LiabilitiesCr
225189228351473528
Non Current Liabilities
Non Current LiabilitiesCr
2328140229292104
Total Liabilities
Total LiabilitiesCr
7688159901,2951,5801,781
Current Assets
Current AssetsCr
423425400508493486
Non Current Assets
Non Current AssetsCr
3453905907871,0871,295
Total Assets
Total AssetsCr
7688159901,2951,5801,781

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
174186918847175
Investing Cash Flow
Investing Cash FlowCr
-96-32-220-206-307-227
Financing Cash Flow
Financing Cash FlowCr
-79151462227836
Net Cash Flow
Net Cash FlowCr
-11-5319-16
Free Cash Flow
Free Cash FlowCr
87-55-155-22-261-50
CFO To PAT
CFO To PAT%
140.422.9281.9184.948.8158.9
CFO To EBITDA
CFO To EBITDA%
89.913.6100.5109.523.473.4
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
174186918847175
Investing Cash Flow
Investing Cash FlowCr
-96-32-220-206-307-227
Financing Cash Flow
Financing Cash FlowCr
-79151462227836
Net Cash Flow
Net Cash FlowCr
-11-5319-16
Free Cash Flow
Free Cash FlowCr
87-55-155-22-261-50
CFO To PAT
CFO To PAT%
140.422.9281.9184.948.8158.9
CFO To EBITDA
CFO To EBITDA%
89.913.6100.5109.523.473.4

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,272
Price To Earnings
Price To Earnings
75.8
Price To Sales
Price To Sales
11.8
Price To Book
Price To Book
7.5
EV To EBITDA
EV To EBITDA
44.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
50.840.337.344.949.551.651.6
OPM
OPM%
30.619.112.223.926.927.427.4
NPM
NPM%
19.611.34.314.212.912.612.6
ROCE
ROCE%
31.416.25.614.512.011.611.6
ROE
ROE%
23.912.94.014.211.99.69.6
ROA
ROA%
16.29.52.57.86.16.26.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,272
Price To Earnings
Price To Earnings
75.8
Price To Sales
Price To Sales
11.8
Price To Book
Price To Book
7.5
EV To EBITDA
EV To EBITDA
44.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
50.840.337.344.949.551.651.6
OPM
OPM%
30.619.112.223.926.927.427.4
NPM
NPM%
19.611.34.314.212.912.612.6
ROCE
ROCE%
31.416.25.614.512.011.611.6
ROE
ROE%
23.912.94.014.211.99.69.6
ROA
ROA%
16.29.52.57.86.16.26.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr17,66916,60811,47010,2728,9845,7515,404
Close PriceClose₹1,436.90849.15548.201,598.60990.70960.40184.12
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE26.3549.9541.0375.8034.99134.7026.61
Price To SalesPS6.589.029.8011.824.164.711.96
RevenueRevenueCr2,6841,8421,1708692,1611,2212,751
Revenue Growth TTMRev Gr TTM%8.2%37.3%4.0%13.4%20.1%26.8%
PAT Growth TTMPAT Gr TTM%26.3%142.2%-13.6%7.1%16.5%75.4%
Market CapitalizationMkt CapCr17,66916,60811,47010,2728,9845,7515,404
Close PriceClose₹1,436.90849.15548.201,598.60990.70960.40184.12
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE26.3549.9541.0375.8034.99134.7026.61
Price To SalesPS6.589.029.8011.824.164.711.96
RevenueRevenueCr2,6841,8421,1708692,1611,2212,751
Revenue Growth TTMRev Gr TTM%8.2%37.3%4.0%13.4%20.1%26.8%
PAT Growth TTMPAT Gr TTM%26.3%142.2%-13.6%7.1%16.5%75.4%
Annual Reports
No recent documents found for this company.
Quarterly Reports
FY2026
Annual Reports
No recent documents found for this company.
Quarterly Reports
Load More
Interviews